Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

932
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
932

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

RPSA-OLFM4 axis governs neutrophil migration against bacterial infection and sepsis.

Nature communications·2026
Same author

Cyclic alternating pattern in sleep electroencephalography as a novel predictor of dementia: A prospective study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Unveiling the prognostic and therapeutic landscape of the zinc transporter protein SLC39A family in colorectal cancer through multi-omics and machine learning approaches.

Clinical and experimental medicine·2026
Same author

Rest-activity rhythms and cardiovascular events in cardiovascular-kidney-metabolic syndrome: evidence from two nationwide cohorts.

American journal of preventive cardiology·2026
Same author

Public Health.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Public Health.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same journal

Correction: Metagenomic and ribosomal transcript profiles of diabetic foot osteomyelitis in Hispanic patients: underestimated bacteria in biofilm persistence.

Frontiers in cellular and infection microbiology·2026
Same journal

Correction: Antigen-specific Th1 cytokine markers and protection against tuberculosis: a systematic review and meta-analysis stratified by progression to active disease and sustained IGRA conversion.

Frontiers in cellular and infection microbiology·2026
Same journal

Microbial dysbiosis and inferred functional profiling reveals the potential role of <i>Methylobacterium</i> in prostate cancer.

Frontiers in cellular and infection microbiology·2026
Same journal

High-risk lineages shape the resistome and virulome of multidrug-resistant <i>Pseudomonas aeruginosa</i>.

Frontiers in cellular and infection microbiology·2026
Same journal

Prevalence and detection of <i>Brucella</i> infection in people with fever of unknown origin in Inner Mongolia, China.

Frontiers in cellular and infection microbiology·2026
Same journal

Editorial: Exploring the interface of mucosal vaccines and immune system modulation.

Frontiers in cellular and infection microbiology·2026
See all related articles

Related Experiment Video

Updated: Jan 10, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

11.1K

Evolving HPV diagnostics: current practice and future frontiers.

Lin Shi1, Haizhen Chen1, Zichen Zhang1

  • 1Department of Clinical Laboratory, The First Hospital of Jilin University, Changchun, China.

Frontiers in Cellular and Infection Microbiology
|November 27, 2025
PubMed
Summary
This summary is machine-generated.

Human papillomavirus (HPV) detection is crucial for preventing cervical cancer. Emerging technologies offer more accurate, accessible, and non-invasive HPV screening methods, improving global health outcomes.

Keywords:
HPV detectionemerging technologiesliquid biopsynon-invasive screeningreal-time PCRtraditional methods

More Related Videos

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

28.1K
Use of Interferon-&#947; Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

12.9K

Related Experiment Videos

Last Updated: Jan 10, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

11.1K
RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

28.1K
Use of Interferon-&#947; Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

12.9K

Area of Science:

  • Oncology
  • Virology
  • Biotechnology

Background:

  • Human papillomavirus (HPV) is a primary cause of cervical cancer.
  • Early detection and screening are vital for reducing HPV-related disease incidence and mortality.
  • Current HPV detection methods face limitations in accessibility and patient compliance, especially in resource-limited settings.

Purpose of the Study:

  • To provide a comprehensive review of established and emerging HPV detection strategies.
  • To analyze the clinical applicability, technical advantages, and limitations of various HPV detection methods.
  • To guide the development of improved HPV detection strategies for global public health initiatives.

Main Methods:

  • Review of conventional HPV detection techniques (e.g., hybrid capture, PCR-based assays).
  • Analysis of emerging HPV detection technologies (e.g., CRISPR/Cas, ddPCR, NGS, IAT, AI-assisted screening).
  • Evaluation of novel sampling methods (e.g., self-collected vaginal swabs, liquid biopsies).

Main Results:

  • Conventional methods offer high sensitivity and specificity but require invasive sampling and centralized labs.
  • Emerging technologies promise enhanced accuracy, rapid results, and point-of-care potential.
  • Innovations in sampling, such as self-collection and liquid biopsy, improve acceptability and coverage.

Conclusions:

  • There is a need for more precise, non-invasive, and scalable HPV detection strategies.
  • Advancements in HPV detection and sampling are critical for reducing the global burden of HPV-related diseases.
  • This review supports global prevention efforts and informs public health policy for HPV screening.